Veterinary / Animal Vaccines Market by Product (Livestock, Companion, Poultry, Equine, Porcine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Swine& Avian Influenza, Strangles) & Technology (Live attenuated, DNA, Inactivated) - Global Forecast to 2020

動物用ワクチンの世界市場:家畜用ワクチン、コンパニオン動物用ワクチン、家禽用ワクチン、馬用ワクチン、豚用ワクチン

◆タイトル:Veterinary / Animal Vaccines Market by Product (Livestock, Companion, Poultry, Equine, Porcine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Swine& Avian Influenza, Strangles) & Technology (Live attenuated, DNA, Inactivated) - Global Forecast to 2020
◆商品コード:MAM-PH-3475
◆調査・発行会社:MarketsandMarkets
◆発行日:2015年6月9日
◆ページ数:186
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、動物用ワクチンの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観、市場シェア分析、製品別分析、病別分析、技術別分析、地域別分析、市場規模及び予測、競争状況、関連企業分析などの情報をお届けいたします。

The report segments the veterinary vaccines market on the basis of products, diseases, technologies, and regions. On basis of products, the veterinary vaccines market is categorized into companion animal vaccines, livestock vaccine, poultry vaccines, porcine vaccines, equine vaccines, aquaculture vaccines, and other animal vaccines. Among these, the companion animal vaccines segment is the fastest-growing segment due to increasing prevalence of zoonotic diseases in humans and growing pet population.
The major animal vaccine production technologies include live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. The DNA vaccines segment is expected to witness highest growth in the forecast period.

New product launches and strategic collaborations were key strategies adopted by major industry players to increase their market share and cater to unmet needs. Emerging and immature markets such as the Middle East, Brazil, Argentina, Mexico, Turkey, China, and India are lucrative markets for veterinary vaccines, owing to favorable government initiatives.

From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the veterinary vaccines market and the product portfolios, developments, and strategies adopted to maintain and increase their market shares. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms, garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product portfolios of the top players in the veterinary vaccines market. The report analyzes the veterinary vaccines market by product and geography
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the veterinary vaccines market
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the veterinary vaccines market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various product across geographies
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the veterinary vaccines market

【レポートの目次】

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 22)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.2.1 Key Data From Secondary Sources
2.2.2 Key Data From Primary Sources
2.2.2.1 Key Industry Insights
2.2.3 Assumptions for the Study

3 Executive Summary (Page No. – 30)

4 Premium Insights (Page No. – 37)
4.1 Veterinary Vaccines Market to Grow at A Steady Rate
4.2 Veterinary Vaccines Market, By Product
4.1 Veterinary Vaccines Market, By Region
4.2 Veterinary Vaccines Market, By Technology
4.3 Lifecycle Analysis, By Region

5 Market Overview (Page No. – 40)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Prevalence of Diseases in Animals
5.2.1.2 Increasing Incidence of Zoonotic Diseases
5.2.1.3 Increasing Investments By Various Government Agencies, Animal Associations, and Leading Players
5.2.1.4 Introduction of New Types of Vaccines
5.2.2 Restraints
5.2.2.1 Rising Maintenance Costs for Storage of Vaccines
5.2.2.2 Increasing Adoption of Vegetarian Food Across Major Economies
5.2.3 Opportunities
5.2.3.1 Technological Innovations Such as DNA Vaccines
5.2.3.2 Growing Awareness of Animal Health in Emerging Economies

6 Veterinary Vaccines Market, By Product (Page No. – 47)
6.1 Introduction

7 Veterinary Vaccines Market, By Disease (Page No. – 50)
7.1 Introduction
7.2 Porcine Vaccines, By Disease
7.3 Porcine Diseases: Overview
7.4 Poultry Vaccines, By Disease
7.5 Poultry Diseases: Overview
7.6 Companion Animal Vaccines, By Disease
7.7 Canine Vaccines
7.8 Canine Diseases: Overview
7.9 Feline Vaccines
7.10 Feline Diseases: Overview
7.11 Livestock Vaccines, By Disease
7.11.1 Bovine Vaccines
7.12 Bovine Diseases: Overview
7.12.1 Small Ruminant Vaccines, By Disease
7.13 Samll Ruminant Diseases: Overview
7.14 Equine Vaccines, By Disease
7.15 Equine Diseases: Overview
7.16 Aquaculture Vaccines, By Disease
7.17 Aquaculture Diseases: Overview

8 Veterinary Vaccines Market, By Technology (Page No. – 68)
8.1 Introduction
8.2 Live Attenuated Vaccines (LAV)
8.3 Inactivated Vaccines
8.4 Toxoid Vaccines
8.5 Recombinant Vaccines
8.6 Conjugate Vaccines
8.7 Subunit Vaccines
8.8 DNA Vaccines

9 Veterinary Vaccines Market, By Region (Page No. – 81)
9.1Introduction
9.2 Europe
9.3 North America
9.4 Asia
9.5 China
9.5.1 Thailand
9.5.1.1 Regulatory Landscape for Veterinary Vaccines in Thailand
9.6 India
9.7 Rest of the World (RoW)
9.8 Brazil

10 Competitive Landscape (Page No. – 157)
10.1 Overview
10.2 Market Share Analysis
10.3 Veterinary Vaccines Market, Major Developments, By Product (2013–2015)
10.3.1 Recent Developments By Market Players (2013–2015)
10.3.1.1 Zoetis (Pfizer)
10.3.1.2 Merck Animal Health
10.3.1.3 Boehringer Ingelheim
10.3.1.4 Ceva Animal Health
10.4 Competitive Situation and Trends
10.4.1 New Product Launches
10.4.2 Agreements, Partnerships, and Collaborations
10.4.3 Acquisitions
10.4.4 Expansion
10.4.5 Other Developments

11 Company Profiles (Page No. – 168)
11.1 1.1 Introduction
11.2 Bayer Healthcare
11.2.1 Business Overview
11.2.2 Product Portfolio
11.2.3 Recent Developments
11.3 Bioniche Animal Health
11.3.1 Business Overview
11.3.2 Product Portfolio
11.3.3 Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Business Overview
11.4.2 Product Portfolio
11.4.3 Recent Developments
11.4.4 MnM View
11.5 Ceva Animal Health
11.5.1 Business Overview
11.5.2 Product Portfolio
11.5.3 Recent Developments
11.6 Elanco Animal Health (Eli Lilly)
11.6.1 Business Overview
11.6.2 Product Portfolio
11.6.3 Recent Developments
11.6.4 MnM View
11.7 Heska Corporation
11.7.1 Business Overview
11.7.2 Product Portfolio
11.7.3 Recent Developments
11.8 Merck Animal Healthcare
11.8.1 Business Overview
11.8.2 Product Portfolio
11.8.3 Recent Developments
11.8.4 MnM View
11.9 Merial Inc. (SANOFI)
11.9.1 Business Overview
11.9.2 Product Portfolio
11.9.3 Recent Developments
11.9.4 MnM View
11.10 Virbac
11.10.1 Business Overview
11.10.2 Product Portfolio
11.10.3 Recent Developments
11.11 Zoetis
11.11.1 Business Overview
11.11.2 Product Portfolio
11.11.3 Recent Developments
11.11.4 MnM View

12 Appendix (Page No. – 193)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports

List of Tables (124 Tables)

Table 1 Growing Incidence of Zoonotic Diseases to Drive the Animal Vaccines Market
Table 2 High Maintenance and Storage Cost of Vaccines to Restrain Market Growth
Table 3 Technological Advancements Likely to Boost the Veterinary Vaccines Market
Table 4 Animal Vaccines Market Size, By Product, 2013–2020 ($Million)
Table 5 Porcine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 6 Poultry Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 7 Canine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 8 Feline Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 9 Bovine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 10 Small Ruminant Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 11 Equine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 12 Aquaculture Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 13 Animal Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 14 Live Attenuated Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 15 Inactivated Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 16 Toxoid Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 17 Recombinant Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 18 Conjugate Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 19 Subunit Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 20 DNA Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 21 Animal Vaccines Market Size, By Region, 2013–2020 ($Million)
Table 22 Europe: Veterinary Vaccines Market Size, By Product, 2013–2020 ($Million)
Table 23 Europe: Porcine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 24 Europe: Porcine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 25 Europe: Livestock Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 26 Europe: Bovine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 27 Europe: Small Ruminant Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 28 Europe: Livestock Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 29 Europe: Poultry Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 30 Europe: Poultry Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 31 Europe: Companion Animal Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 32 Europe: Canine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 33 Europe: Feline Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 34 Europe: Companion Animal Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 35 Europe: Equine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 36 Europe: Equine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 37 Europe: Aquaculture Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 38 Europe: Aquaculture Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 39 North America: Animal Vaccines Market Size, By Product, 2013–2020 ($Million)
Table 40 North America: Porcine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 41 North America: Porcine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 42 North America: Livestock Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 43 North America: Bovine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 44 North America: Small Ruminant Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 45 North America: Livestock Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 46 North America: Poultry Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 47 North America: Poultry Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 48 North America: Companion Animal Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 49 North America: Canine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 50 North America: Feline Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 51 North America: Companion Animal Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 52 North America: Equine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 53 North America: Equine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 54 North America: Aquaculture Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 55 North America: Aquaculture Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 56 China: Animal Vaccines Market Size, By Product, 2013–2020 ($Million)
Table 57 China: Porcine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 58 China: Porcine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 59 China: Livestock Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 60 China: Bovine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 61 China: Small Ruminant Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 62 China: Livestock Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 63 China: Poultry Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 64 China: Poultry Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 65 China: Companion Animal Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 66 China: Canine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 67 China: Feline Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 68 China: Companion Animal Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 69 China: Equine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 70 China: Equine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 71 China: Aquaculture Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 72 China: Aquaculture Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 73 Thailand: Veterinary Vaccines Market Size, By Product, 2013–2020 ($Million)
Table 74 Thailand: Porcine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 75 Thailand: Porcine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 76 Thailand: Poultry Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 77 Thailand: Poultry Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 78 Thailand: Companion Animal Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 79 Thailand: Canine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 80 Thailand: Feline Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 81 Thailand: Companion Animal Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 82 Thailand: Livestock Animal Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 83 Thailand: Bovine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 84 Thailand: Small Ruminant Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 85 Thailand: Livestock Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 86 India: Animal Vaccines Market Size, By Product, 2013–2020 ($Million)
Table 87 India: Porcine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 88 India: Porcine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 89 India: Livestock Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 90 India: Bovine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 91 India: Small Ruminant Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 92 India: Livestock Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 93 India: Poultry Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 94 India: Poultry Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 95 India: Companion Animal Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 96 India: Canine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 97 India: Feline Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 98 India: Companion Animal Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 99 India: Equine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 100 India: Equine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 101 India: Aquaculture Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 102 India: Aquaculture Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 103 Brazil: Veterinary Vaccines Market Size, By Product, 2013–2020 ($Million)
Table 104 Brazil: Porcine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 105 Brazil: Porcine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 106 Brazil: Livestock Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 107 Brazil: Bovine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 108 Brazil: Small Ruminant Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 109 Brazil: Livestock Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 110 Brazil: Poultry Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 111 Brazil: Poultry Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 112 Brazil: Companion Animal Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 113 Brazil: Canine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 114 Brazil: Feline Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 115 Brazil: Companion Animal Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 116 Brazil: Equine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 117 Brazil: Equine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 118 Brazil: Aquaculture Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 119 Brazil: Aquaculture Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 120 New Product Launches, 2013–2015
Table 121 Agreements, Partnerships, and Collaborations, 2013–2015
Table 122 Acquisitions, 2013-2015
Table 123 Expansions, 2013-2015
Table 124 Other Developments, 2012–2015

List of Figures (65 Figures)

Figure 1 Research Design: Veterinary Vaccines Market
Figure 2 Market Size Estimation
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Data Triangulation Methodology
Figure 5 Animal Vaccines Market Snapshot (2015 vs. 2020): Companion Animal Vaccines Segment to Grow at the Highest CAGR
Figure 6 Live Attenuated Vaccines Segment is Expected to Dominate the Animal Vaccines Technologies Market in 2015
Figure 7 Asia-Pacific Market to Witness the Highest Growth During the Forecast Period
Figure 8 Figure 1 Attractive Market Opportunities
Figure 9 Porcine Vaccines Segment Accounted for the Largest Share in 2014
Figure 10 Asia is Expected to Be the Fastest-Growing Region During the Forecast Period
Figure 11 Live Attenuated Vaccines Technology Segment is Expected to Dominate the Animal Vaccines Market During the Forecast Period
Figure 12 Increasing Incidence of Zoonotic Diseases to Boost Market Growth
Figure 13 Porcine Vaccines Commanded Largest Share of the Veterinary Vaccines Market in 2014
Figure 14 Porcine Circovirus Segment Projected to Grow at Highest Rate in Porcine Vaccines Market, By 2020
Figure 15 Infectious Bronchitis Segment Dominated the Poultry Vaccines Market in 2014
Figure 16 Canine Distemper Segment Projected to Grow at Highest Rate in Canine Vaccines Market By 2020
Figure 17 Feline Rabies Segment Dominated Feline Vaccines Market in 2014
Figure 18 BVD Segment Projected to Grow at Highest Rate in Bovine Vaccines Market By 2020
Figure 19 Clostridial Diseases Segment Dominated the Small Ruminant Vaccines Market in 2014
Figure 20 Equine Rhinopneumonitis Segment Projected to Grow at Highest Rate in Equine Vaccines Market By 2020
Figure 21 Vibriosis Segment Dominated the Aquaculture Vaccines Market in 2014
Figure 22 Live Attenuated Vaccines Dominated the Global Animal Vaccines Market in 2014
Figure 23 Poultry Vaccines Dominated the Live Attenuated Vaccines Market in 2014
Figure 24 Companion Animal Vaccines to Witness the Highest Growth Rate in the Inactivated Vaccines Market By 2020
Figure 25 Livestock Vaccines Dominated the Toxoid Vaccines Market in 2014
Figure 26 Porcine Vaccines to Grow at the Highest Rate in the Recombinant Vaccines Market By 2020
Figure 27 Porcine Vaccines Dominated the Conjugate Vaccines Market in 2014
Figure 28 Livestock Vaccines to Grow at the Highest Rate in the Subunit Vaccines Market By 2020
Figure 29 Porcine Vaccines Dominated the DNA Vaccines Market in 2014
Figure 30 Geographic Snapshot Asia to Witness the Highest Growth in the Forecast Period
Figure 31 Asia, an Attractive Destination for All Product Categories
Figure 32 Europe Will Continue to Lead the Global Veterinary Vaccines Market in the Forecast Period
Figure 33 The Demand for Animal Vaccines Will Be Driven By the Growing Production of Pig Meat in the Forecast Period
Figure 34 The Porcine Vaccines Segment Accounted for the Largest Share of the European Veterinary Vaccines Market, By Product
Figure 35 Recombinant Vaccines Technology Will Be the Fastest-Growing Segmenting European Veterinary Vaccines Market in the Forecast Period
Figure 36 The Inactivated Vaccines Technology Segment Accounted for the Largest Share of the European Companion Animal Vaccines Market
Figure 37 The Live Attenuated Vaccines Technology Segment Accounted for the Largest Share of the North America Livestock Vaccines Market
Figure 38 Asia Market Snapshot: the Demand for Veterinary Vaccines Will Be Driven By Increasing Incidences of Zoonotic Diseases
Figure 39 The Livestock Vaccines Segment Accounted for the Largest Share of the Veterinary Vaccines Market in China
Figure 40 Conjugate Vaccines Technology Will Be the Fastest-Growing Segment for Asian Animal Vaccines Market in the Forecast Period
Figure 41 The Porcine Vaccines Segment Accounted for the Largest Share of the Thailand Veterinary Vaccines Market
Figure 42 Recombinant Vaccine Technology Segment to Witness the Highest Growth Thailand Veterinary Vaccines Market in the Forecast Period
Figure 43 The Livestock Vaccines Segment Accounted for the Largest Share of the Animal Vaccines Market in India
Figure 44 Conjugate Vaccines Technology Segment to Witness the Highest Growth in Livestock Vaccines Market the Forecast Period
Figure 45 The Poultry Vaccines Segment Accounted for the Largest Share of the Animal Vaccines Market in Brazil
Figure 46 Inactivated Vaccines Technology Segment to Grow at the Highest CAGR in Poultry Vaccines Market in the Forecast Period
Figure 47 Companies Adopted New Product Launches and Licenses as Their Key Growth Strategy (2013-2015)
Figure 48 Global Animal Vaccines Market Share, By Key Player, 2014
Figure 49 Animal Vaccines Market, Major Developments (2013–2015)
Figure 50 Zoetis (Pfizer) Focused on Porcine Segment in Last Few Years (2013-2015)
Figure 51 Merck Concentrated on Livestock Segment (2013-2015)
Figure 52 Boehringer Ingelheim Mainly Concentrated on Equine Segment (2013-2015)
Figure 53 Ceva Released New Products for the Poultry Segment (2013 – 2015)
Figure 54 Battle for Market Share: New Product Launches Was the Key Growth Strategy
Figure 55 Geographic Revenue Mix of Top Five Market Players
Figure 56 Bayer Healthcare: Company Snapshot
Figure 57 Bioniche Animal Health: Company Snapshot
Figure 58 Boehringer Ingelheim: Company Snapshot
Figure 59 Ceva Animal Health: Company Snapshot
Figure 60 Elanco Animal Health: Company Snapshot
Figure 61 Heska Corporation: Company Snapshot
Figure 62 Merck Animal Healthcare: Company Snapshot
Figure 63 Merial Inc. (SANOFI): Company Snapshot
Figure 64 Virbac: Company Snapshot
Figure 65 Zoetis: Company Snapshot

【レポートのキーワード】

動物用ワクチン、家畜用ワクチン、コンパニオン動物用ワクチン、家禽用ワクチン、馬用ワクチン、豚用ワクチン、治療、弱毒生ワクチン、不活性化ワクチン、トキソイドワクチン、DNAワクチン

★調査レポート[動物用ワクチンの世界市場:家畜用ワクチン、コンパニオン動物用ワクチン、家禽用ワクチン、馬用ワクチン、豚用ワクチン] ( Veterinary / Animal Vaccines Market by Product (Livestock, Companion, Poultry, Equine, Porcine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Swine& Avian Influenza, Strangles) & Technology (Live attenuated, DNA, Inactivated) - Global Forecast to 2020 / MAM-PH-3475) 販売に関する免責事項
[動物用ワクチンの世界市場:家畜用ワクチン、コンパニオン動物用ワクチン、家禽用ワクチン、馬用ワクチン、豚用ワクチン] ( Veterinary / Animal Vaccines Market by Product (Livestock, Companion, Poultry, Equine, Porcine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Swine& Avian Influenza, Strangles) & Technology (Live attenuated, DNA, Inactivated) - Global Forecast to 2020 / MAM-PH-3475) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆